James A LevySummaryAffiliation: University of Utah Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's diseaseJames A Levy
Department of Neurology, Center for Alzheimer s Care, Imaging and Research, University of Utah, Salt Lake City, UT 84108, USA
J Geriatr Psychiatry Neurol 20:227-38. 2007..For temporal variants of frontotemporal lobar degenerations, progressive aphasia and semantic dementia, worse language performance relative to AD is typically characteristic...
Effects of previous major depressive illness on cognition in Alzheimer disease patientsH Eleanor Cannon-Spoor
Geriatric Psychiatry Branch, NIMH, Bethesda, MD 20892 1274, USA
Am J Geriatr Psychiatry 13:312-8. 2005....
Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's diseaseJames A Levy
Geriatric Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
J Int Neuropsychol Soc 10:362-70. 2004....
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 alleleTrey Sunderland
National Institute of Mental Health, Geriatric Psychiatry Branch, Building 10, Room 3N228, 9000 Rockville Pike, Bethesda, MD 20892, USA
Biol Psychiatry 56:670-6. 2004..We tested these CSF markers in groups of subjects with AD and healthy older control subjects, using the absence or presence of the APOE epsilon4 allele as a predictive variable in the search for possible prognostic biomarkers of AD...
Circadian preference and cognitive functioning among rehabilitation inpatientsChristine V Paradee
Wayne State University, Detroit, MI 48202, USA
Clin Neuropsychol 19:55-72. 2005..Cognitive reserve theory is suggested as an explanation for the differential effects. These findings may have implications for inpatient therapeutic interventions and discharge planning...
Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patientsEdward D Huey
Geriatric Psychiatry Branch, National Institute of Mental Health, Bethesda, MD, USA
Dement Geriatr Cogn Disord 22:48-53. 2006..Cerebrospinal fluid (CSF) measures of beta-amyloid(1-42 )and tau differ between patients with Alzheimer's Disease (AD) and elderly normal controls. The effect of time and APOE genotype on these biomarkers continues to be elucidated...
